Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference



Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc.
(Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and
development of novel small molecule therapeutics, today announced that
Mohammad Azab, MD, chief medical officer, and Michael Molkentin, chief
financial officer, will present at the 2013 RBC Capital Markets Healthcare
Conference on Wednesday, February 27^th in New York City.

The Company's presentation will begin at 8:00 a.m. ET. A live webcast of the
presentation will be available in the Investor Events section of the Company's
website, www.astx.com. The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel
small molecule therapeutics with a focus on oncology. The Company is
developing a proprietary pipeline of novel therapies and is creating de-risked
products for partnership with leading pharmaceutical companies. Astex
Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives
significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit
http://www.astx.com.

The Astex Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=12273

CONTACT: Timothy L. Enns
         Astex Pharmaceuticals, Inc.
         Senior Vice President
         Corporate Communications & Marketing
         Tel:  +1 (925) 560-2810
         E-mail:  tim.enns@astx.com

         Susanna Chau
         Astex Pharmaceuticals, Inc.
         Manager
         Investor Relations
         Tel:  +1 (925) 560-2845
         E-mail:  susanna.chau@astx.com

         Alan Roemer
         The Trout Group
         Managing Director
         Tel:  +1 (646) 378-2945
         E-mail: aroemer@troutgroup.com

Astex Pharmaceuticals, Inc. logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement